Does OSIMERTINIB Cause Hepatic function abnormal? 248 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 248 reports of Hepatic function abnormal have been filed in association with OSIMERTINIB (TAGRISSO). This represents 0.9% of all adverse event reports for OSIMERTINIB.
248
Reports of Hepatic function abnormal with OSIMERTINIB
0.9%
of all OSIMERTINIB reports
24
Deaths
104
Hospitalizations
How Dangerous Is Hepatic function abnormal From OSIMERTINIB?
Of the 248 reports, 24 (9.7%) resulted in death, 104 (41.9%) required hospitalization, and 10 (4.0%) were considered life-threatening.
Is Hepatic function abnormal Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OSIMERTINIB. However, 248 reports have been filed with the FAERS database.
What Other Side Effects Does OSIMERTINIB Cause?
Death (10,423)
Malignant neoplasm progression (2,920)
Diarrhoea (1,408)
Drug resistance (1,026)
Fatigue (819)
Rash (772)
Decreased appetite (706)
Drug ineffective (627)
Dyspnoea (621)
Nausea (610)
What Other Drugs Cause Hepatic function abnormal?
NIVOLUMAB (1,131)
PEMBROLIZUMAB (1,079)
METHOTREXATE (1,054)
CABOZANTINIB S-MALATE (912)
CYCLOPHOSPHAMIDE (824)
BEVACIZUMAB (769)
PACLITAXEL (603)
LENVATINIB (528)
ATORVASTATIN (520)
CYCLOSPORINE (508)
Which OSIMERTINIB Alternatives Have Lower Hepatic function abnormal Risk?
OSIMERTINIB vs OSPEMIFENE
OSIMERTINIB vs OSPHENA
OSIMERTINIB vs OVINE DIGOXIN IMMUNE FAB
OSIMERTINIB vs OXACILLIN
OSIMERTINIB vs OXALIPLATIN